Since ΙΚΚε has been shown to activate the NF-κB pathway and cooperate with MEK to induce transformation in breast cells, the sensitivity of the breast cancer cells to inhibiting ΙΚΚε, IKKβ or MEK was assessed. This evidence concerns the gene NFKB1 and breast carcinoma.